Agile Therapeutics Announces Favorable Outcome of FDA Advisory Committee Meeting for its Investigational Transdermal Contraceptive Patch, Twirla® (AG200-15)
Stock Information for Agile Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.